Results 121 to 130 of about 1,950 (155)

Pseudohypoxia induced by iron chelators preserves working memory performance in aged mice. [PDF]

Sci Rep
Ohara T, Iwasaki Y, Kasai T, Yamashita T, Komaki S, Hamada Y, Fujisawa M, Matsukawa A.   +7 more
europepmc   +1 more source

Effect of Roxadustat on Cardiometabolism in Healthy Individuals (ROXACardioMeta): Protocol for a Double-Blind, Placebo-Controlled and Randomised Cross-Over Trial. [PDF]

Methods Protoc
Klemola E, Tapio J, Valtonen RIP, Tulppo MP, Hukkanen J, Koivunen P.   +5 more
europepmc   +1 more source

Application of high-flux hemodialysis combined with hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of renal anemia in patients with uremia: A randomized controlled trial. [PDF]

Medicine (Baltimore)
Chen J, Gong A, Lin Y, Zhang C, Guo J.
europepmc   +1 more source

Efficacy and safety of prolyl hydroxylase inhibitors for anemia in chronic kidney disease: a network meta-analysis. [PDF]

Ren Fail
Niu Y, Wang T, Zhan Y, Xu H, Li C, Hu Z, He J, Li Y, Fang Y.   +8 more
europepmc   +1 more source

Mechanistic Evaluation of Roxadustat for Pulmonary Fibrosis: Integrating Network Pharmacology, Transcriptomics, and Experimental Validation. [PDF]

Pharmaceuticals (Basel)
Zhang C, Huang X, Ye H, Tang H, Huang M, Jia S, Shao J, Wu J, Yao X.   +8 more
europepmc   +1 more source

Roxadustat for renal anemia: current clinical experience. [PDF]

Front Pharmacol
Ji J, Li Z, Fang S, Li Z.
europepmc   +1 more source

Targeted hypoxia-inducible factor 1-alpha (HIF1A) stabilization during in vitro maturation of bovine cumulus-oocyte complexes increases blastocyst rates. [PDF]

Sci Rep
Gübeli M, Bleul U, Kowalewski MP.
europepmc   +1 more source

Roxadustat attenuates contrast-induced acute kidney injury potentially mediated via the Nrf2/HO-1 signaling pathway. [PDF]

Ren Fail
Wang J, E JW, Zhang J.
europepmc   +1 more source

Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs. [PDF]

Medeni Med J
Tanriverdi LH, Sarici A, Erkurt MA, Berktas HB.   +3 more
europepmc   +1 more source

Frequency-reduction strategy of roxadustat in patients undergoing peritoneal dialysis: a multi-center retrospective cohort study. [PDF]

Front Med (Lausanne)
Mi X, Lin G, Fang Y, Zhu L, Lin Y, Zhang T, Zhong X, Su X, Dou X, Ai J.   +9 more
europepmc   +1 more source